Related Experiment Video
Updated: May 3, 2026
11:57
Using an α-Bungarotoxin Binding Site Tag to Study GABA A Receptor Membrane Localization and Trafficking
Published on: March 28, 2014
14.7K
Anxiety over GABA(A) receptor structure relieved by AChBP
Brett A Cromer1, Craig J Morton, Michael W Parker
1Biota Structural Biology Laboratory, St. Vincent's Institute of Medical Research, 9 Princes Street, Fitzroy, Victoria 3065, Australia. b.cromer@medicine.unimelb.edu.au
Trends in Biochemical Sciences
|June 19, 2002
Summary
Researchers developed a new 3D model for the GABA(A) receptor
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- The GABA(A) receptor is crucial for inhibitory neurotransmission in the brain.
- It is a key target for drugs like benzodiazepines and anesthetics.
- Limited high-resolution structural data has hindered understanding of its molecular mechanisms.
Purpose of the Study:
- To create a novel molecular model of the GABA(A) receptor's extracellular ligand-binding domain.
- To integrate existing biochemical and mutational data into a structural framework.
- To provide new insights into GABA and benzodiazepine binding sites and allosteric modulation.
Main Methods:
- Development of a new structural model for the GABA(A) receptor's ligand-binding domain.
- Utilizing the recently determined structure of a soluble acetylcholine-binding protein as a template.
- Integrating and contextualizing existing mutational and biochemical data within the new 3D model.
Main Results:
- A detailed 3D model of the GABA(A) receptor's extracellular domain is presented.
- The model provides structural context for known GABA and benzodiazepine binding sites.
- It highlights the role of specific regions in allosteric conformational changes.
Conclusions:
- The new model offers a valuable perspective on existing data concerning the GABA(A) receptor.
- It establishes a framework for further research into this important class of receptors.
- This structural insight can advance the understanding of neuromodulatory drug actions.
More Related Videos
07:51Inhibitory Synapse Formation in a Co-culture Model Incorporating GABAergic Medium Spiny Neurons and HEK293 Cells Stably Expressing GABAA Receptors
Published on: November 14, 2014
19.5K
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
14.1K
Related Concept Videos
01:12GPCR Desensitization
6.1K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.1K
01:21G-Protein Gated Ion Channels
5.5K
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Sensory...
5.5K
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
4.6K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
4.6K
01:26Anxiolytic Drugs: Overview
1.5K
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
1.5K
01:29Anxiolytic Drugs: Benzodiazepines and Buspirone
3.1K
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
3.1K
01:30Generalized Anxiety Disorder
1.3K
Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...
1.3K